Rockwell Medical (RMTI) Free Cash Flow (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Free Cash Flow came in at -$625000.0 in Q1 2026, up 82.39% YoY from -$342664.1 in Q1 2025, and down 128.88% on a QoQ basis from $2.2 million in Q4 2025.
Rockwell Medical (RMTI) Free Cash Flow (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 17 years of Free Cash Flow data on file, last reported at -$625000.0 in Q1 2026.
- Quarterly Free Cash Flow rose 82.39% year-over-year to -$625000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (down 22.08% YoY) and the FY2025 annual result came in at -$1.2 million, down 138.92% from the prior year.
- Free Cash Flow fell to -$625000.0 in Q1 2026, from $2.2 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $4.1 million in Q3 2024 to a low of -$9.8 million in Q1 2022.
- A 5-year average of -$1.5 million and a median of -$1.0 million in 2022 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2023 — Free Cash Flow slumped 268.79% — and 2024, when it soared 646.51%.
- Tracing RMTI's Free Cash Flow over 5 years: stood at -$393000.0 in 2022, then jumped by 78.12% to -$86000.0 in 2023, then soared by 646.51% to $470000.0 in 2024, then soared by 360.43% to $2.2 million in 2025, then tumbled by 128.88% to -$625000.0 in 2026.
- The last three Free Cash Flow figures came in at -$625000.0 (Q1 2026), $2.2 million (Q4 2025), and -$1.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Rockwell Medical | 31.73 Mn | 6.93 Mn | 3.24 Mn | 1.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.50 Mn |
| Jun 30, 2026 | 1.50 Mn |
| Mar 31, 2026 | -625,000.00 |
| Mar 31, 2026 | -625,000.00 |
| Dec 31, 2025 | 2.16 Mn |
| Dec 31, 2025 | 2.16 Mn |
| Sep 30, 2025 | -1.58 Mn |
| Sep 30, 2025 | -1.58 Mn |
| Jun 30, 2025 | 1.72 Mn |
| Jun 30, 2025 | 1.72 Mn |
| Mar 31, 2025 | -3.55 Mn |
| Mar 31, 2025 | -3.55 Mn |
| Dec 31, 2024 | 470,000.00 |
| Dec 31, 2024 | 470,000.00 |
| Sep 30, 2024 | 4.08 Mn |
| Sep 30, 2024 | 4.08 Mn |
| Jun 30, 2024 | 1.16 Mn |
| Jun 30, 2024 | 1.16 Mn |
| Mar 31, 2024 | -2.52 Mn |
| Mar 31, 2024 | -2.52 Mn |